BLIS Technologies Limited (NZE: BLT)

New Zealand flag New Zealand · Delayed Price · Currency is NZD
0.0120
-0.0010 (-7.69%)
Sep 25, 2024, 11:39 AM NZST
-45.45%
Market Cap 15.35M
Revenue (ttm) 11.57M
Net Income (ttm) 646.00K
Shares Out 1.28B
EPS (ttm) 0.00
PE Ratio 24.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,598,373
Open 0.0120
Previous Close 0.0130
Day's Range 0.0120 - 0.0120
52-Week Range 0.0110 - 0.0240
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 17, 2024

About BLIS Technologies

BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company offers BLIS K12, an oral probiotic supplement to support ear, nose, and throat health, as well as for enhancing immunity and bad breath; BLIS M18, an oral probiotic to support teeth and gums health; and BLIS Q24, a probiotic supplement to balance the skin microbiome, restoring the health, clarity, and radiance. It has operations in New Zealand, Asia Pacific, Europe, the Mid... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 39
Stock Exchange New Zealand Stock Exchange
Ticker Symbol BLT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.